Current status of hepatic glycogen storage disease in Japan: Clinical manifestations, treatments and long-term outcomes

Journal of Human Genetics

Volumn 58, Issue 5, 2013, Pages 285-292

  Kido, Jun ^a   Nakamura, Kimitoshi ^a   Matsumoto, Shirou ^a   Mitsubuchi, Hiroshi ^a   Ohura, Toshihiro ^b   Shigematsu, Yosuke ^c   Yorifuji, Tohru ^d   Kasahara, Mureo ^e   Horikawa, Reiko ^e   Endo, Fumio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SENDAI CITY HOSPITAL   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

^e NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

adenoma; g727t; glycogen storage disease; height; hepatocellular carcinoma; liver transplantation; renal dysfunction; W118R

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STARCH;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONVULSION; DIET RESTRICTION; DIET THERAPY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 3; GLYCOGEN STORAGE DISEASE TYPE 4; GLYCOGEN STORAGE DISEASE TYPE 6; GROWTH RETARDATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERLIPIDEMIA; HYPERURICEMIA; HYPOGLYCEMIA; JAPAN; KIDNEY DYSFUNCTION; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROGNOSIS; PROTEINURIA; QUALITY OF LIFE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOGEN STORAGE DISEASE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LIVER TRANSPLANTATION; MALE; PROGNOSIS; YOUNG ADULT;

ZEA MAYS;

EID: 84878565107     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2013.17     Document Type: Article

References (49)

1. Chen, Y. T., Coleman, R. A., Scheinman, J. I., Kolbeck, P. C. & Sidbury, J. B. Renal disease in type I glycogen storage disease. N. Engl. J. Med. 318, 7-11 (1988).
2. Reitsma-Bierens, W. C. Renal complications in glycogen storage disease type I. Eur. J. Pediatr. 152 (Suppl 1), S60-S62 (1993).
3. Zangeneh, F., Limbeck, G. A., Brown, B. I., Emch, J. R., Arcasoy, M. M., Goldenberg, V. E. et al. Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver. J. Pediatr. 74, 73-83 (1969).
4. Franco, L. M., Krishnamurthy, V., Bali, D., Weinstein, D. A., Arn, P., Clary, B. et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J. Inherit. Metab. Dis. 28, 153-162 (2005).
5. Parvari, R., Moses, S., Shen, J., Hershkovitz, E., Lerner, A. & Chen, Y. T. A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients. Eur. J. Hum. Genet. 5, 266-270 (1997).
6. Shen, J., Shen, J., Bao, Y., Liu, H. M., Lee, P., Leonard, J. V. et al. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J. Clin. Invest. 98, 352-357 (1996).
7. Moses, S. W., Wanderman, K. L., Myroz, A. & Frydman, M. Cardiac involvement in glycogen storage disease type III. Eur. J. Pediatr. 148, 764-766 (1989).
8. L'Hermine-Coulomb, A., Beuzen, F., Bouvier, R., Rolland, M. O., Froissart, R., Menez, F. et al. Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family. Am. J. Med. Genet. A 139A, 118-122 (2005).
9. Andersen, D. H. Familial cirrhosis of the liver with storage of abnormal glycogen. Lab. Invest. 5, 11-20 (1956).
10. Selby, R., Starzl, T. E., Yunis, E., Brown, B. I., Kendall, R. S., Tzakis, A. et al. Liver transplantation for type IV glycogen storage disease. N. Engl. J. Med. 324, 39-42 (1991).
11. Willems, P. J., Gerver, W. J., Berger, R. & Fernandes, J. The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. Eur. J. Pediatr. 149, 268-271 (1990).
12. Manz, F., Bickel, H., Brodehl, J., Feist, D., Gellissen, K., Gescho? ll-Bauer, B. et al. Fanconi-Bickel syndrome. Pediatr. Nephrol. 1, 509-518 (1987).
13. Bhattacharya, K., Orton, R. C., Qi, X., Mundy, H., Morley, D. W., Champion, M. P. et al. A novel starch for the treatment of glycogen storage diseases. J. Inherit. Metab. Dis. 30, 350-357 (2007).
14. Chen, Y. T., Cornblath, M. & Sidbury, J. B. Cornstarch therapy in type I glycogen-storage disease. N. Engl. J. Med. 310, 171-175 (1984).
15. Lee, P. J., Van't Hoff, W. G. & Leonard, J. V. Catch-up growth in Fanconi-Bickel syndrome with uncooked cornstarch. J. Inherit. Metab. Dis. 18, 153-156 (1995).
16. Bandsma, R. H., Prinsen, B. H., van Der Velden Mde, S., Rake, J. P., Boer, T., Smit, G. P. et al. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr. Res. 63, 702-707 (2008).
17. Rake, J. P., Visser, G., Labrune, P., Leonard, J. V., Ullrich, K. & Smit, G. P. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur. J. Pediatr. 161 (Suppl 1), S20-S34 (2002).
18. Rake, J. P., Visser, G., Labrune, P., Leonard, J. V., Ullrich, K. & Smit, G. P. Guidelines for management of glycogen storage disease type I -European Study on Glycogen Storage Disease Type I (ESGSD I). Eur. J. Pediatr. 161 (Suppl 1), S112-S119 (2002).
19. Melis, D., Parenti, G., Gatti, R., Casa, R. D., Parini, R., Riva, E. et al. Efficacy of ACEinhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study. Clin. Endocrinol. (Oxf) 63, 19-25 (2005).
20. Koeberl, D. D., Pinto, C., Sun, B., Li, S., Kozink, D. M., Benjamin, D. K. Jr et al. AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia. Mol. Ther. 16, 665-672 (2008).
21. Lee, Y. M., Jun, H. S., Pan, C. J., Lin, S. R., Wilson, L. H., Mansfield, B. C. et al. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy. Hepatology 56, 1719-1729 (2012).
22. Bhattacharya, N., Heaton, N., Rela, M., Walter, J. H. & Lee, P. J. The benefits of liver transplantation in glycogenosis type Ib. J. Inherit. Metab. Dis. 27, 539-540 (2004).
23. Faivre, L., Houssin, D., Valayer, J., Brouard, J., Hadchouel, M., Bernard, O. et al. Longterm outcome of liver transplantation in patients with glycogen storage disease type Ia. J. Inherit. Metab. Dis. 22, 723-732 (1999).
24. Iyer, S. G., Chen, C. L., Wang, C. C., Wang, S. H., Concejero, A. M., Liu, Y. W. et al. Long-term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl. 13, 848-852 (2007).
25. Matern, D., Starzl, T. E., Arnaout, W., Barnard, J., Bynon, J. S., Dhawan, A. et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur. J. Pediatr. 158 (Suppl 2), S43-S48 (1999).
26. Smit, G. P. The long-term outcome of patients with glycogen storage disease type Ia. Eur. J. Pediatr. 152 (Suppl 1), S52-S55 (1993).
27. Smit, G. P., Fernandes, J., Leonard, J. V., Matthews, E. E., Moses, S. W., Odievre, M. et al. The long-term outcome of patients with glycogen storage diseases. J. Inherit. Metab. Dis. 13, 411-418 (1990).
28. Talente, G. M., Coleman, R. A., Alter, C., Baker, L., Brown, B. I., Cannon, R. A. et al. Glycogen storage disease in adults. Ann. Intern. Med. 120, 218-226 (1994).
29. Kido, J., Nakamura, K., Mitsubuchi, H., Ohura, T., Takayanagi, M., Matsuo, M. et al. Long-term outcome and intervention of urea cycle disorders in Japan. J. Inherit. Metab. Dis. 35, 777-785 (2012).
30. Akanuma, J., Nishigaki, T., Fujii, K., Matsubara, Y., Inui, K., Takahashi, K. et al. Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells. Am. J. Med. Genet. 91, 107-112 (2000).
31. Hou, D. C., Kure, S., Suzuki, Y., Hasegawa, Y., Hara, Y., Inoue, T. et al. Glycogen storage disease type Ib: structural and mutational analysis of the microsomal glucose-6-phosphate transporter gene. Am. J. Med. Genet. 86, 253-257 (1999).
32. Labrune, P., Trioche, P., Duvaltier, I., Chevalier, P. & Odievre, M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J. Pediatr. Gastroenterol. Nutr. 24, 276-279 (1997).
33. Bianchi, L. Glycogen storage disease I and hepatocellular tumours. Eur. J. Pediatr. 152 (Suppl 1), S63-S70 (1993).
34. Nakamura, K., Tanaka, Y., Mitsubuchi, H. & Endo, F. Animal models of tyrosinemia. J. Nutr. 137, 1556S-1560S, discussion 1573S-1575S (2007).
35. Nakamura, T., Ozawa, T., Kawasaki, T., Nakamura, H. & Sugimura, H. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors. J. Gastroenterol. Hepatol. 16, 1402-1408 (2001).
36. Urushihara, M., Kagami, S., Ito, M., Yasutomo, K., Kondo, S., Kitamura, A. et al. Transforming growth factor-beta in renal disease with glycogen storage disease I. Pediatr. Nephrol. 19, 676-678 (2004)
37. Talaat, K. M. & El-Sheikh, A. R. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am. J. Nephrol. 27, 435-440 (2007).
38. Wolf, G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int. 70, 1914-1919 (2006).
39. Keane, W. F. The role of lipids in renal disease: future challenges. Kidney Int. Suppl. 75, S27-S31 (2000).
40. Wolfsdorf, J. I., Laffel, L. M. & Crigler, J. F. Jr. Metabolic control and renal dysfunction in type I glycogen storage disease. J. Inherit. Metab. Dis. 20, 559-568 (1997).
41. Kalogirou, M., Tsimihodimos, V., Gazi, I., Filippatos, T., Saougos, V., Tselepis, A. D. et al. Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia. Curr. Med. Res. Opin. 23, 1169-1176 (2007).
42. Oki, Y., Okubo, M., Tanaka, S., Nakanishi, K., Kobayashi, T., Murase, T. et al. Diabetes mellitus secondary to glycogen storage disease type III. Diabet. Med. 17, 810-812 (2000).
43. Spiegel, R., Rakover-Tenenbaum, Y., Mandel, H., Lumelski, D., Admoni, O., Horovitz, Y. et al. Secondary diabetes mellitus: late complication of glycogen storage disease type 1b. J. Pediatr. Endocrinol. Metab. 18, 617-619 (2005).
44. Lerut, J. P., Ciccarelli, O., Sempoux, C., Danse, E., deFlandre, J., Horsmans, Y. et al. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl. Int. 16, 879-884 (2003).
45. Kasahara, M., Horikawa, R., Sakamoto, S., Shigeta, T., Tanaka, H., Fukuda, A. et al. Living donor liver transplantation for glycogen storage disease type Ib. Liver Transpl. 15, 1867-1871 (2009).
46. Davis, M. K. & Weinstein, D. A. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure. Pediatr. Transplant. 12, 137-145 (2008).
47. Maheshwari, A., Rankin, R., Segev, D. L. & Thuluvath, P. J. Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature. Clin. Transplant. 26, 432-436 (2012).
48. Liu, P. P., de Villa, V. H., Chen, Y. S., Wang, C. C., Wang, S. H., Chiang, Y. C. et al. Outcome of living donor liver transplantation for glycogen storage disease. Transplant. Proc. 35, 366-368 (2003).
49. Reddy, S. K., Austin, S. L., Spencer-Manzon, M., Koeberl, D. D., Clary, B. M., Desai, D. M. et al. Liver transplantation for glycogen storage disease type Ia. J. Hepatol. 51, 483-490 (2009).